Placebo News and Research

RSS

New drug receives FDA approval to reduce risk of cardiovascular death in adults with diabetes

The U.S. Food and Drug Administration today approved a new indication for Jardiance (empagliflozin) to reduce the risk of cardiovascular death in adult patients with type 2 diabetes mellitus and cardiovascular disease.

2 Dec 2016

Alpha blockers benefit patients with larger kidney stones

Nearly one in 11 Americans will have a kidney stone in their lifetime, causing pain, sometimes missed work and, often, a lot of money.

2 Dec 2016

Hallucinogenic drug offers relief for people with cancer-related anxiety or depression

In a small double-blind study, Johns Hopkins researchers report that a substantial majority of people suffering cancer-related anxiety or depression found considerable relief for up to six months from a single large dose of psilocybin -- the active compound in hallucinogenic "magic mushrooms."

2 Dec 2016

Drexel researchers one step closer to offering new treatment for chronic wounds

Drexel University researchers are one step closer to offering a new treatment for the millions of patients who suffer from slow-healing, chronic wounds.

29 Nov 2016

Study shows heart medications prevent cardiovascular damage during breast cancer treatment

Heart medication taken in combination with chemotherapy reduces the risk of serious cardiovascular damage in patients with early-stage breast cancer, according to results from a new landmark clinical trial.

29 Nov 2016

NIH-supported first HIV vaccine efficacy study begins in South Africa

The first HIV vaccine efficacy study to launch anywhere in seven years is now testing whether an experimental vaccine regimen safely prevents HIV infection among South African adults.

28 Nov 2016

Pharmacotherapy combined with rehabilitation program offers hope for traumatic brain injury patients

Pharmacological therapy combined with a rehabilitation program that teaches how to compensate for memory and attention problems offers new hope for people who suffer the consequences of traumatic brain injury.

24 Nov 2016

Clinically-proven pharmacy product effective against causes of Traveller's Diarrhoea

It is not only overseas holidays that can be ruined by the dreaded Traveller's Diarrhoea.

23 Nov 2016

Dietary supplement extracted from Amaranthus can increase plasma nitrate, study shows

A new, clinical study confirms that dietary supplementation of nitrate from a natural extract of Amaranthus species nicknamed "red spinach," results in a significant increase in plasma nitrite that ultimately enhances nitric oxide.

23 Nov 2016

New combinatination therapy shows promise in treating patients with traumatic brain injury

A combination of the stimulant drug methylphenidate with a process known as cognitive-behavioral rehabilitation is a promising option to help people who suffer from persistent cognitive problems following traumatic brain injury, researchers at Indiana University School of Medicine have reported.

22 Nov 2016

Vitamin D supplementation improves autism symptoms, study shows

Vitamin D supplementation improved symptoms of autism in a recent trial.

21 Nov 2016

Results of high-impact clinical trials could improve kidney-related medical care

The results of numerous high-impact clinical trials that could affect kidney-related medical care will be presented at ASN Kidney Week 2016, November 15-20 at McCormick Place in Chicago, IL.

21 Nov 2016

Walnuts could be key to happier state-of-mind in young healthy men

College can be a stressful time for young adults as they figure out how to manage intense daily routines that include work, study and play.

18 Nov 2016

Dietary sodium restriction may provide kidney and heart benefits for CKD patients

New research indicates that reducing sodium intake may provide kidney and heart benefits for patients with chronic kidney disease (CKD).

17 Nov 2016

Arthritis drug induces response and remission in patients with Crohn's disease, study finds

Researchers at University of California San Diego School of Medicine have shown that ustekinumab, a human antibody used to treat arthritis, significantly induces response and remission in patients with moderate to severe Crohn's disease.

17 Nov 2016

NYU Langone-led study to examine longer-term use of suppressive antiviral medication to reduce shingles

NYU Langone Medical Center will lead a five-year, 60-center clinical trial to evaluate new treatment protocols for herpes zoster ophthalmicus (HZO), a form of shingles that can seriously and permanently affect the eye.

17 Nov 2016

FDA approval of controversial drug for Duchenne muscular dystrophy raises concern and hope

In September, the Food and Drug Administration approved Exondys, a controversial treatment for Duchenne muscular dystrophy based on tenuous data from just 12 patients.

17 Nov 2016

Study finds many parents agree to use of placebos in children

Placebos are essential in any controlled clinical trial, providing a yardstick against which the test drug is measured.

15 Nov 2016

Research sheds new light on how humans learn to behave under uncertainty

New research has revealed how three important brain signaling chemicals affect the way that we handle uncertainty.

15 Nov 2016

Statins can help prevent first time heart attacks, strokes in adults with cardiovascular risk factors

Cholesterol-lowering drugs help prevent heart attacks and strokes in adults with cardiovascular risk factors such as high cholesterol, high blood pressure, diabetes and smoking, but have not yet had a heart attack or stroke, according to a large-scale analysis of clinical trial data led by the OHSU Pacific Northwest Evidence-Based Practice Center.

14 Nov 2016

Placebo News and Research

New drug receives FDA approval to reduce risk of cardiovascular death in adults with diabetes

Alpha blockers benefit patients with larger kidney stones

Hallucinogenic drug offers relief for people with cancer-related anxiety or depression

Drexel researchers one step closer to offering new treatment for chronic wounds

Study shows heart medications prevent cardiovascular damage during breast cancer treatment

NIH-supported first HIV vaccine efficacy study begins in South Africa

Pharmacotherapy combined with rehabilitation program offers hope for traumatic brain injury patients

Clinically-proven pharmacy product effective against causes of Traveller's Diarrhoea

Dietary supplement extracted from Amaranthus can increase plasma nitrate, study shows

New combinatination therapy shows promise in treating patients with traumatic brain injury

Vitamin D supplementation improves autism symptoms, study shows

Results of high-impact clinical trials could improve kidney-related medical care

Walnuts could be key to happier state-of-mind in young healthy men

Dietary sodium restriction may provide kidney and heart benefits for CKD patients

Arthritis drug induces response and remission in patients with Crohn's disease, study finds

NYU Langone-led study to examine longer-term use of suppressive antiviral medication to reduce shingles

FDA approval of controversial drug for Duchenne muscular dystrophy raises concern and hope

Study finds many parents agree to use of placebos in children

Research sheds new light on how humans learn to behave under uncertainty

Statins can help prevent first time heart attacks, strokes in adults with cardiovascular risk factors

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News